Immunodiagnostic Systems Holdings plc provided group revenue guidance for the six months ended September 30, 2018. For the period, unaudited group revenues are expected to be £18.5 million, 1% lower than the same period last year. On a like for like basis, that is at constant exchange rate and scope, group revenues were in line with the same period last year.